Medtronic has secured FDA approval for its OmniaSecure defibrillation lead to be used in conduction system pacing, the first device cleared for left bundle branch area placement. The small, lumenless ...

Biotronik announced today that it received FDA approval for its Acticor Sky and Rivacor implantable defibrillator systems.

Yet the evidence should not be overinterpreted, as conventional pacing maintains an important role, says Elena Arbelo.

Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive ...

Medtronic plc (NYSE:MDT) is one of the 7 Most Undervalued Blue Chip Stocks to Invest In. On March 23, 2026, Medtronic plc (NYSE:MDT) received U.S. FDA approval for an expanded indication for its ...

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (MDT), a ...

GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded ...

iData Research: Global Cardiac Rhythm Management market to hit $36B by 2032. Leadless pacing and pulsed field ablation lead the industry. Pulsed field ablation, and leadless pacing are expanding the ...